Nanotechnology and cancer.

The biological picture of cancer is rapidly advancing from models built from phenomenological descriptions to network models derived from systems biology, which can capture the evolving pathophysiology of the disease at the molecular level. The translation of this (still academic) picture into a clinically relevant framework can be enabling for the war on cancer, but it is a scientific and technological challenge. In this review, we discuss emerging in vitro diagnostic technologies and therapeutic approaches that are being developed to handle this challenge. Our discussion of in vitro diagnostics is guided by the theme of making large numbers of measurements accurately, sensitively, and at very low cost. We discuss diagnostic approaches based on microfluidics and nanotechnology. We then review the current state of the art of nanoparticle-based therapeutics that have reached the clinic. The goal of the presentation is to identify nanotherapeutic strategies that are designed to increase efficacy while simultaneously minimizing the toxic side effects commonly associated with cancer chemotherapies.

[1]  H. Kantarjian,et al.  Molecular monitoring in chronic myeloid leukemia , 2008, Cancer.

[2]  D. Gilliland,et al.  A role for JAK2 mutations in myeloproliferative diseases. , 2008, Annual review of medicine.

[3]  John P. Moore,et al.  Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. , 2008, Annual review of medicine.

[4]  A. Zaas,et al.  The effect of toll-like receptors and toll-like receptor genetics in human disease. , 2008, Annual review of medicine.

[5]  A. Ventura,et al.  Genetic determinants of aggressive breast cancer. , 2008, Annual review of medicine.

[6]  Michael C. McAlpine,et al.  Highly ordered nanowire arrays on plastic substrates for ultrasensitive flexible chemical sensors. , 2007, Nature materials.

[7]  Mark E. Davis,et al.  Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA , 2007, Proceedings of the National Academy of Sciences.

[8]  Hanlee P. Ji,et al.  Multiplexed protein detection by proximity ligation for cancer biomarker validation , 2007, Nature Methods.

[9]  Fei Huang,et al.  Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. , 2007, Cancer research.

[10]  Mark E. Davis,et al.  Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. , 2007, Bioconjugate chemistry.

[11]  L. Hood,et al.  Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas , 2007, Proceedings of the National Academy of Sciences.

[12]  Gabriel A Kwong,et al.  DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins. , 2007, Journal of the American Chemical Society.

[13]  Martin Hegner,et al.  Cantilever Array Sensors for Bioanalysis and Diagnostics , 2007 .

[14]  James R. Heath.  Label‐Free Nanowire and Nanotube Biomolecular Sensors for In‐Vitro Diagnosis of Cancer and other Diseases , 2007 .

[15]  M. Roukes,et al.  Ultra-sensitive NEMS-based cantilevers for sensing, scanned probe and very high-frequency applications. , 2007, Nature nanotechnology.

[16]  R. M. Owen,et al.  Selective tumor cell targeting using low-affinity, multivalent interactions. , 2007, ACS chemical biology.

[17]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[18]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[19]  James R Heath,et al.  Quantitative real-time measurements of DNA hybridization with alkylated nonoxidized silicon nanowires in electrolyte solution. , 2006, Journal of the American Chemical Society.

[20]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[21]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[22]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[23]  Shuming Nie,et al.  Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.

[24]  R. Morishita,et al.  Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties , 2006, TheScientificWorldJournal.

[25]  A. Undar,et al.  A microfluidic device for continuous, real time blood plasma separation. , 2006, Lab on a chip.

[26]  David G Myszka,et al.  Screening antibody-antigen interactions in parallel using Biacore A100. , 2006, Analytical biochemistry.

[27]  Luke P. Lee,et al.  Nanoliter scale microbioreactor array for quantitative cell biology , 2006, Biotechnology and bioengineering.

[28]  Hongtao Zhang,et al.  A sensitive and high-throughput assay to detect low-abundance proteins in serum , 2006, Nature Medicine.

[29]  Hongyue Dai,et al.  Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  David M Lubman,et al.  Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. , 2006, Analytical chemistry.

[31]  F. Monzon.  A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer , 2006 .

[32]  T. Laurell,et al.  Continuous separation of lipid particles from erythrocytes by means of laminar flow and acoustic standing wave forces. , 2005, Lab on a chip.

[33]  W. Zamboni.  Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents , 2005, Clinical Cancer Research.

[34]  Hamid Bolouri,et al.  A data integration methodology for systems biology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Sludden,et al.  A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules , 2005, Clinical Cancer Research.

[36]  H. Lang,et al.  A label-free immunosensor array using single-chain antibody fragments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Gengfeng Zheng,et al.  Multiplexed electrical detection of cancer markers with nanowire sensor arrays , 2005, Nature Biotechnology.

[38]  Chao Li,et al.  Complementary detection of prostate-specific antigen using In2O3 nanowires and carbon nanotubes. , 2005, Journal of the American Chemical Society.

[39]  T. Crowley,et al.  Isolation of plasma from whole blood using planar microfilters for lab-on-a-chip applications. , 2005, Lab on a chip.

[40]  William Pao,et al.  Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Mehmet Toner,et al.  Blood-on-a-chip. , 2005, Annual review of biomedical engineering.

[42]  C. Larabell,et al.  Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.

[43]  M. Fishman,et al.  Final results of a phase I study of liposome encapsulated SN-38 (LE-SN38): Safety, pharmacogenomics, pharmacokinetics, and tumor response , 2005 .

[44]  Patrick Hunziker,et al.  Modeling and Optimization of High-Sensitivity, Low-Volume Microfluidic-Based Surface Immunoassays , 2005, Biomedical microdevices.

[45]  Michael Hawkins,et al.  Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) , 2005, Clinical Cancer Research.

[46]  Judy Lieberman,et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.

[47]  Mark M. Davis,et al.  Cellular immunotherapy: antigen recognition is just the beginning , 2005, Springer Seminars in Immunopathology.

[48]  P. Shannon,et al.  Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. , 2005, Cancer research.

[49]  Chad A Mirkin,et al.  Nanostructures in biodiagnostics. , 2005, Chemical reviews.

[50]  P. Sheehan,et al.  Detection limits for nanoscale biosensors. , 2005, Nano letters.

[51]  A. Ramachandran,et al.  Lipopolysaccharide microarrays for the detection of antibodies. , 2005, Journal of immunological methods.

[52]  Michael E Phelps,et al.  Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  J. Griffin,et al.  After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. , 2005, Blood.

[54]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[55]  Ping Chen,et al.  Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. , 2004, Journal of medicinal chemistry.

[56]  Michael E Phelps,et al.  Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.

[57]  Gengfeng Zheng,et al.  Electrical detection of single viruses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[59]  B. Druker,et al.  Molecularly targeted therapy: have the floodgates opened? , 2004, The oncologist.

[60]  J. Sturm,et al.  Continuous Particle Separation Through Deterministic Lateral Displacement , 2004, Science.

[61]  C. Sawyers,et al.  Targeted cancer therapy , 2004, Nature.

[62]  Mark M Davis,et al.  Detection and Characterizationof Cellular Immune Responses Using Peptide–MHC Microarrays , 2003, PLoS biology.

[63]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[64]  T. Allen.  Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[65]  S. Quake,et al.  Microfluidic Large-Scale Integration , 2002, Science.

[66]  Frederick F Becker,et al.  Microsample preparation by dielectrophoresis: isolation of malaria. , 2002, Lab on a chip.

[67]  C. Mirkin,et al.  Array-Based Electrical Detection of DNA with Nanoparticle Probes , 2002, Science.

[68]  C. Lieber,et al.  Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species , 2001, Science.

[69]  X. H. Chen,et al.  Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  M. Roederer,et al.  11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity , 2001, Nature Medicine.

[71]  S. Htoy.  New additions to the oncology arsenal: Assessing their place in therapy , 2001 .

[72]  G. Prestwich,et al.  Photopatterning of antibodies on biosensors. , 2000, Bioconjugate chemistry.

[73]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[74]  S. Kingsmore,et al.  Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Quake,et al.  Monolithic microfabricated valves and pumps by multilayer soft lithography. , 2000, Science.

[76]  Kong,et al.  Nanotube molecular wires as chemical sensors , 2000, Science.

[77]  S. Quake,et al.  A microfabricated fluorescence-activated cell sorter , 1999, Nature Biotechnology.

[78]  T. Chinowsky,et al.  Quantitative interpretation of the response of surface plasmon resonance sensors to adsorbed films , 1998 .

[79]  R S Foote,et al.  Microchip device for cell lysis, multiplex PCR amplification, and electrophoretic sizing. , 1998, Analytical chemistry.

[80]  G. Whitesides,et al.  Soft Lithography. , 1998, Angewandte Chemie.

[81]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.

[82]  J. Hatzfeld,et al.  An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors. , 1995, Experimental hematology.

[83]  L. Javois.  Immunocytochemical methods and protocols , 1994 .

[84]  E. Engvall,et al.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. , 1972, Journal of immunology.

[85]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[86]  A. H. Coons,et al.  Fluorescent Antibody Studies with Agents of Varicella and Herpes Zoster Propagated in vitro.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.